ADELMIDROL FOR USE IN DISEASES CHARACTERIZED BY INSUFFICIENT AGONISM OF PPAR-GAMMA RECEPTOR

ADELMIDROL FOR USE IN DISEASES CHARACTERIZED BY INSUFFICIENT AGONISM OF PPAR-GAMMA RECEPTOR

Abstract The present invention relates to a pharmaceutical composition containing Adelmidrol. In particular, the present invention concerns Adelmidrol for use in the treatment of diseases characterized by insufficient specific agonism of the PPAR-gamma receptor in humans or animals, more particularl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Della Valle, Francesco, Cuzzocrea, Salvatore, Della Valle, Maria Federica
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Della Valle, Francesco
Cuzzocrea, Salvatore
Della Valle, Maria Federica
description Abstract The present invention relates to a pharmaceutical composition containing Adelmidrol. In particular, the present invention concerns Adelmidrol for use in the treatment of diseases characterized by insufficient specific agonism of the PPAR-gamma receptor in humans or animals, more particularly in the treatment of articular chondropathies of mechanical, toxic, iatrogenic, degenerative origin, or associated with inflammatory phenomena mainly related to organs and tissues not belonging to the osteoarticular system; fibrogenesis of the articular cartilages; chronic inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis; Irritable Bowel Syndrome (IBS); diseases characterized by an abnormal fibrosis of the connective tissue, such as systemic sclerosis, particularly of the skin and lung; eye disorders characterized by angiogenesis, fibrosis, inflammation and oxidative stress.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2022201087CC1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2022201087CC1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2022201087CC13</originalsourceid><addsrcrecordid>eNqNyrEOgjAQgGEWB6O-ww2uJFAHXc_2CpdQSq5lQAdCTJ2MkuD7RwcfwOkfvn-dXdFQ49iIb8B6gT4QcAuGA2GgALpGQR1J-EIGzsMXQ28ta6Y2Ala-5eDAW-g6lLxC5xCENHXRyzZb3afHkna_brK9pajrPM2vMS3zdEvP9B6xV4VSqiiL01Hr8vDn9gGRyjMs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ADELMIDROL FOR USE IN DISEASES CHARACTERIZED BY INSUFFICIENT AGONISM OF PPAR-GAMMA RECEPTOR</title><source>esp@cenet</source><creator>Della Valle, Francesco ; Cuzzocrea, Salvatore ; Della Valle, Maria Federica</creator><creatorcontrib>Della Valle, Francesco ; Cuzzocrea, Salvatore ; Della Valle, Maria Federica</creatorcontrib><description>Abstract The present invention relates to a pharmaceutical composition containing Adelmidrol. In particular, the present invention concerns Adelmidrol for use in the treatment of diseases characterized by insufficient specific agonism of the PPAR-gamma receptor in humans or animals, more particularly in the treatment of articular chondropathies of mechanical, toxic, iatrogenic, degenerative origin, or associated with inflammatory phenomena mainly related to organs and tissues not belonging to the osteoarticular system; fibrogenesis of the articular cartilages; chronic inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis; Irritable Bowel Syndrome (IBS); diseases characterized by an abnormal fibrosis of the connective tissue, such as systemic sclerosis, particularly of the skin and lung; eye disorders characterized by angiogenesis, fibrosis, inflammation and oxidative stress.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240111&amp;DB=EPODOC&amp;CC=AU&amp;NR=2022201087C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240111&amp;DB=EPODOC&amp;CC=AU&amp;NR=2022201087C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Della Valle, Francesco</creatorcontrib><creatorcontrib>Cuzzocrea, Salvatore</creatorcontrib><creatorcontrib>Della Valle, Maria Federica</creatorcontrib><title>ADELMIDROL FOR USE IN DISEASES CHARACTERIZED BY INSUFFICIENT AGONISM OF PPAR-GAMMA RECEPTOR</title><description>Abstract The present invention relates to a pharmaceutical composition containing Adelmidrol. In particular, the present invention concerns Adelmidrol for use in the treatment of diseases characterized by insufficient specific agonism of the PPAR-gamma receptor in humans or animals, more particularly in the treatment of articular chondropathies of mechanical, toxic, iatrogenic, degenerative origin, or associated with inflammatory phenomena mainly related to organs and tissues not belonging to the osteoarticular system; fibrogenesis of the articular cartilages; chronic inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis; Irritable Bowel Syndrome (IBS); diseases characterized by an abnormal fibrosis of the connective tissue, such as systemic sclerosis, particularly of the skin and lung; eye disorders characterized by angiogenesis, fibrosis, inflammation and oxidative stress.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEOgjAQgGEWB6O-ww2uJFAHXc_2CpdQSq5lQAdCTJ2MkuD7RwcfwOkfvn-dXdFQ49iIb8B6gT4QcAuGA2GgALpGQR1J-EIGzsMXQ28ta6Y2Ala-5eDAW-g6lLxC5xCENHXRyzZb3afHkna_brK9pajrPM2vMS3zdEvP9B6xV4VSqiiL01Hr8vDn9gGRyjMs</recordid><startdate>20240111</startdate><enddate>20240111</enddate><creator>Della Valle, Francesco</creator><creator>Cuzzocrea, Salvatore</creator><creator>Della Valle, Maria Federica</creator><scope>EVB</scope></search><sort><creationdate>20240111</creationdate><title>ADELMIDROL FOR USE IN DISEASES CHARACTERIZED BY INSUFFICIENT AGONISM OF PPAR-GAMMA RECEPTOR</title><author>Della Valle, Francesco ; Cuzzocrea, Salvatore ; Della Valle, Maria Federica</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2022201087CC13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Della Valle, Francesco</creatorcontrib><creatorcontrib>Cuzzocrea, Salvatore</creatorcontrib><creatorcontrib>Della Valle, Maria Federica</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Della Valle, Francesco</au><au>Cuzzocrea, Salvatore</au><au>Della Valle, Maria Federica</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ADELMIDROL FOR USE IN DISEASES CHARACTERIZED BY INSUFFICIENT AGONISM OF PPAR-GAMMA RECEPTOR</title><date>2024-01-11</date><risdate>2024</risdate><abstract>Abstract The present invention relates to a pharmaceutical composition containing Adelmidrol. In particular, the present invention concerns Adelmidrol for use in the treatment of diseases characterized by insufficient specific agonism of the PPAR-gamma receptor in humans or animals, more particularly in the treatment of articular chondropathies of mechanical, toxic, iatrogenic, degenerative origin, or associated with inflammatory phenomena mainly related to organs and tissues not belonging to the osteoarticular system; fibrogenesis of the articular cartilages; chronic inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis; Irritable Bowel Syndrome (IBS); diseases characterized by an abnormal fibrosis of the connective tissue, such as systemic sclerosis, particularly of the skin and lung; eye disorders characterized by angiogenesis, fibrosis, inflammation and oxidative stress.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2022201087CC1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ADELMIDROL FOR USE IN DISEASES CHARACTERIZED BY INSUFFICIENT AGONISM OF PPAR-GAMMA RECEPTOR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T05%3A05%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Della%20Valle,%20Francesco&rft.date=2024-01-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2022201087CC1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true